by admin | Apr 7, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Roughly 168,000 veterans receiving care have Alzheimer’s dementia By Joseph Walker – The Wall Street journal Eisai Co.’s new Alzheimer’s disease drug Leqembi will be covered by the U.S. Department of Veterans Affairs, the first major insurer to agree to pay for...
by admin | Apr 6, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Tina Reed – Axios Digital health and biotech firms made up a substantial part of Silicon Valley Bank’s client base. And its historic failure is raising troubling questions about how much the fallout will hurt emerging health companies in need of...
by admin | Mar 31, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Gabrielle Masson – Fierce Biotech News Athenex is in a tight spot, trying to stretch out its remaining cash and ward off an unruly creditor just as the FDA slaps a clinical hold on its neuroblastoma cell therapy while it explores a patient’s death in a...
by admin | Mar 30, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Nicole Mlynaryk – University of California Sab Diego News UC San Diego scientists find stem cells’ unique way of discarding misfolded proteins could be the key to maintaining long-term health and preventing disease In humanity’s ongoing quest for the elixir of...
by admin | Mar 27, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Linda Wang – UCLA Health A research team led by Dr. Thomas Rando, director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, has discovered that restoring glutathione—a key antioxidant that prevents cell...
by admin | Mar 24, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Tim Hornyak – Nature Successes in life sciences and international collaboration could be key to boosting the country’s high-quality output. After five years studying genome editing at Harvard Medical School in Boston, Massachusetts, Keiji Nishida returned to...
